Downregulation of cyclin A2 (Ccna2), Polo-like kinase 1 (Plk1) and the centromer protein A (Cenpa) which are typically upregulated in tumour cells to foster cell cycle and mitosis agree well with the observed cell cycle arrest and demonstrate the therapeutic effect of these experimental inhibitors. The gene discussed is PLK1; the disease is neoplasm.